Experience with dasatinib and nilotinib use in pregnancy

Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial

(2016) A Hochhaus et al.   LEUKEMIA

The impact of dasatinib on pregnancy outcomes

(2015) Jorge E. Cortes et al.   AMERICAN JOURNAL OF HEMATOLOGY

Managing pregnancy in chronic myeloid leukaemia

(2015) Renuka Palani et al.   ANNALS OF HEMATOLOGY

Outcome of 3 pregnancies in a patient with chronic myeloid leukemia who received 3 types of tyrosine kinase inhibitors each in different pregnancy: follow-up of the case with a review of published reports

(2015) Hussain Alizadeh et al.   ANNALS OF SAUDI MEDICINE

Discontinuation of dasatinib in patients with chronic myeloid leukaemia who have maintained deep molecular response for longer than 1 year (DADI trial): a multicentre phase 2 trial

(2015) Jun Imagawa et al.   Lancet Haematology

TYROSINE KINASE INHIBITORS AND PREGNANCY

(2014) Elisabetta Abruzzese et al.   Mediterranean Journal of Hematology and Infectious Diseases

Early response with dasatinib or imatinib in chronic myeloid leukemia: 3-year follow-up from a randomized phase 3 trial (DASISION)

(2013) E. Jabbour et al.   BLOOD

Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER study

(2013) D. M. Ross et al.   BLOOD

A dramatic fetal outcome following transplacental transfer of dasatinib

(2012) Paul Berveiller et al.   ANTI-CANCER DRUGS

A systematic review to calculate background miscarriage rates using life table analysis

(2012) Lyndsay Ammon Avalos et al.   BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY

A systematic review of the fetal safety of interferon alpha

(2011) P. Yazdani Brojeni et al.   REPRODUCTIVE TOXICOLOGY

Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial

(2010) François-Xavier Mahon et al.   LANCET ONCOLOGY

Successful management of pregnancy occurring in a patient with chronic myeloid leukemia on dasatinib

(2010) Tara Kroll et al.   LEUKEMIA & LYMPHOMA

Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

(2010) Hagop Kantarjian et al.   NEW ENGLAND JOURNAL OF MEDICINE

Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia

(2010) Giuseppe Saglio et al.   NEW ENGLAND JOURNAL OF MEDICINE

Two successful pregnancies in a woman with chronic myeloid leukemia exposed to nilotinib during the first trimester of her second pregnancy: case study

(2009) Monika Conchon et al.   Journal of Hematology & Oncology

The effects of imatinib on pregnancy outcome

(2008) S. M. Pye et al.   BLOOD

Lacteal Secretion, Fetal and Maternal Tissue Distribution of Dasatinib in Rats

(2008) K. He et al.   DRUG METABOLISM AND DISPOSITION